Neoplasms/*radiotherapy ; *Uterine Cervical Neoplasms ; *Vaginal Smears

Brachytherapy* ; Radiotherapy ; Rectum* ; Uterine Cervical Neoplasms

Vaginal evisceration is a rare complication after a hysterectomy, especially a radical hysterectomy. Up to now, there have only been three cases of transvaginal evisceration after radical hysterectomy reported in the English literature. We report one case of transvaginal evisceration occurring after radical hysterectomy and adjuvant radiotherapy for stage IIA cervical cancer, with a brief review of the literature.
Hysterectomy ; Radiotherapy, Adjuvant ; Uterine Cervical Neoplasms

The authors noticed that the original version of this paper contains typographical error in Fig. 2.
Body Weight* ; Humans ; Radiotherapy* ; Uterine Cervical Neoplasms*

Evaluating activities of erythrocyte antioxidant enzymes and plasma total antioxidant status of 60 patients with the Ib and IIa stage cervical cancer post radiotherapy treated with Belaf and those of 35 healthy controls. The results: Activities of erythrocyte SOD, GPx and GR of the patients significantly decreased compared to those in patients pre radiotherapy. The decrease was likely to recover at the 21st day after radiotherapy. TAS levels of the patients post radiotherapy decreased compared to pre radiotherapy and recovered in 21st day post radiotherapy treated with Belaf
Uterine Cervical Neoplasms ; Plasma ; Antioxidants ; Radiotherapy

Study on 62 patients with the stage Ib and IIa cervical cancer pre- and post- radiotherapy and 30 healthy controls aged from 30-35 years old. The result showed that activites of antioxidant enzymes (SOD, GPx and GR) of patients with the stage Ib and IIa cervical cancer were significantly decreased compared to those of healthy controls. Activites of these enzyms clearly decreased post-radiotherapy, and more clearly at the 21st day post-radiotherapy. TAS and Hb concentration of cancer patient decreased compared with control group and they trend to recover at the 21st day post-radiotherapy
Enzymes ; Antioxidants ; Erythrocytes ; Uterine Cervical Neoplasms ; Radiotherapy

In brachytherapy of uterine cervical cancer using the high dose rate remote afterloading system, it is of prime importance to determine the position of the radiation sources and to estimate the irradiation time. However, calculation with manual method is so time consuming and laborious, that authors designed a software as an aid to intracavitary radiotherapy planning using the personal computer to obtain the precision of treatment without being too complicated for routine use. Optimal source arrangement in combination with dose rate at each specific points and irradiation time can be easily determined using this software in several minutes.
Brachytherapy* ; Microcomputers ; Radiotherapy ; Uterine Cervical Neoplasms*

We present a case of cervical cancer treated by concurrent chemoradiation. In radiation therapy part, the combination of the whole pelvic helical tomotherapy plus image-guided brachytherapy with megavoltage computed tomography of helical tomotherapy was performed. We propose this therapeutic approach could be considered in a curative setting in some problematic situation as our institution.
Brachytherapy* ; Radiotherapy, Intensity-Modulated ; Uterine Cervical Neoplasms*

We present a case of cervical cancer treated by concurrent chemoradiation. In radiation therapy part, the combination of the whole pelvic helical tomotherapy plus image-guided brachytherapy with megavoltage computed tomography of helical tomotherapy was performed. We propose this therapeutic approach could be considered in a curative setting in some problematic situation as our institution.
Brachytherapy* ; Radiotherapy, Intensity-Modulated ; Uterine Cervical Neoplasms*

In brachytherapy of uterine cervical cancer using a high dose rate remote afterloading system, it is of prime importance to deliver a accurate dose in each fractionated treatment by minimizing the difference between the pre-treatment planned and post-treatment calculated doses. The post-treatment calculated point A dose was not much different from the pretreatment planned dose (500 cGy). The average+/-standard deviation was 500+/-18 cGy and 84 percent of 82 intracavitary radiotherapy was within the range of 500+/-25 cGy.
Brachytherapy ; Cervix Uteri* ; Female ; Radiotherapy* ; Uterine Cervical Neoplasms